These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7808786)

  • 1. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can cytotoxic activity of anthracyclines be related to DNA damage?
    Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
    Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice.
    Yin MB; Bankusli I; Rustum YM
    Cancer Res; 1989 Sep; 49(17):4729-33. PubMed ID: 2758408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
    Bellamy WT; Dorr RT; Dalton WS; Alberts DS
    Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.
    Jensen PB; Jensen PS; Demant EJ; Friche E; Sørensen BS; Sehested M; Wassermann K; Vindeløv L; Westergaard O; Hansen HH
    Cancer Res; 1991 Oct; 51(19):5093-9. PubMed ID: 1655244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB; Bankusli I; Frank C; Rustum YM
    Anticancer Res; 1990; 10(2A):327-32. PubMed ID: 2346306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
    Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
    Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y
    Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T; Robert J
    Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
    Harker WG; Sikic BI
    Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
    Chambers SK; Hait WN; Kacinski BM; Keyes SR; Handschumacher RE
    Cancer Res; 1989 Nov; 49(22):6275-9. PubMed ID: 2804973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML; Hoeltge GA; Dalton WS; Trent JM
    Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
    Ling YH; Priebe W; Yang LY; Burke TG; Pommier Y; Perez-Soler R
    Cancer Res; 1993 Apr; 53(7):1583-9. PubMed ID: 8453627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and action mechanism of anthracyclines].
    Fukushima T; Ueda T; Nakamura T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular accumulation and cytotoxic effect of (8-thiotheophyllinate) (triphenylphosphine) gold(I) in Friend leukemia cells.
    Arizti MP; Garcia-Orad A; Sommer F; Silvestro L; Massiot P; Chevallier P; Gutiérrez-Zorrilla JM; Colacio E; Martinez de Pancorbo M; Tapiero H
    Anticancer Res; 1991; 11(2):625-8. PubMed ID: 2064317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
    Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
    Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.